tiprankstipranks
Trending News
More News >
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market

Ajanta Pharma Limited (AJANTPHARM) Income Statement

Compare
3 Followers

Ajanta Pharma Limited Income Statement

Last quarter (Q4 2025), Ajanta Pharma Limited's total revenue was ₹11.70B, an increase of 11.04% from the same quarter last year. In Q4, Ajanta Pharma Limited's net income was ₹2.25B. See Ajanta Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 46.48B₹ 42.09B₹ 37.43B₹ 32.84B₹ 28.47B
Gross Profit
₹ 35.77B₹ 30.93B₹ 26.92B₹ 23.97B₹ 21.65B
Operating Expenses
₹ 13.14B₹ 11.20B₹ 20.40B₹ 15.86B₹ 12.72B
Depreciation and Amortization
₹ 1.44B₹ 1.35B₹ 1.30B₹ 1.25B₹ 1.16B
EBITDA
₹ 12.68B₹ 12.57B₹ 8.81B₹ 10.44B₹ 10.24B
Operating Income
₹ 22.64B₹ 19.68B₹ 6.62B₹ 8.08B₹ 8.90B
Other Income/Expenses
₹ -10.74B₹ -8.54B₹ 341.80M₹ -6.86B₹ 364.60M
Pretax Income
₹ 11.89B₹ 11.14B₹ 7.45B₹ 9.09B₹ 9.00B
Net Income
₹ 9.20B₹ 8.16B₹ 5.88B₹ 7.13B₹ 6.54B
Per Share Metrics
Basic EPS
₹ 73.56₹ 64.82₹ 45.89₹ 54.97₹ 50.06
Diluted EPS
₹ 73.53₹ 64.77₹ 45.89₹ 54.96₹ 50.06
Weighted Average Shares Outstanding
125.17M 125.92M 128.12M 129.66M 130.62M
Weighted Average Shares Outstanding (Diluted)
125.17M 126.01M 128.12M 129.66M 130.62M
Currency in INR

Ajanta Pharma Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis